Monday, July 7, 2025
17.9 C
London
HomeFundingImugene: Receives $4.8M tax rebate on cancer research

Imugene: Receives $4.8M tax rebate on cancer research

Date:

Zopa Opens New Office in Manchester: Expanding Its Presence

Discover how Zopa is reshaping the fintech landscape in...

Pair Sentenced to Jail for $15M Crypto Fraud Scheme

A Deep Dive into the Conviction of Cryptocurrency FraudstersHighlights:...

Trump Proposes Tariff Rates of Up to 70% as New Letters Are Sent Out

Exploring the Implications of Donald Trump's Proposed Tariffs on...
  • Clinical-stage immuno-oncology company Imugene (IMU) has received a hefty tax rebate for its research and development (R&D) spending
  • The company has banked a little over $4.82 M as part of the Australian government’s R&D tax incentive program
  • The scheme also provides eligible Australian companies with an offset or refund of up to 43.5 percent of annual research spending
  • Then the company has a number of therapies in the pipeline to treat tumours, harnessing the body’s immune system to fight cancer’s growth and spread
  • With an extra $4.82M on hand, the company will well funded and resourced to continue the development of its potentially life-saving immunotherapies
  • Imugene closed Thursday’s session grey at 11.5. cents

Related stories

spot_img

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Latest stories